Recursos de colección

ORBi Open Repository and Bibliography (327.254 recursos)

In may 2007, the ULg's Administrative Board (joined in June 2007 by the FUSAGx) decided to create an institutional repository and defined a strong institutional self-archiving policy to increase the visibility, accessibility and impact of the University's publications (Board's decision). This decision led to the official launch, in November 2008, of the ORBi platform including both the Academic Bibliography and the Institutional Repository of the Wallonia-Europe University Academy.

Human health sciences => Laboratory medicine & medical technology

Mostrando recursos 1 - 20 de 95

  1. CARDIAC BIOMARKERS FLUCTUATION IN RUNNERS OF MARATHONS, SEMI-MARATHONS AND UNTRAINED RUNNERS

    Le Goff, Caroline; VRANKEN, Laura; Kaux, Jean-François; Lennartz, Lieselotte; Cavalier, Etienne
    Peer reviewed

  2. Dentin Matrix Protein 1 (DMP1) for use in pharmaceutical compositions

    Castronovo, Vincenzo; Bellahcene, Akeila; Pirotte, Sophie
    The present invention refers to Dentin Matrix Protein 1 (DMP1) or a polynucleotide encoding Dentin Matrix Protein 1, for use for reducing and/or preventing angiogenesis and for use in the preventive and/or therapeutic treatment of angiogenesis-related diseases.

  3. Biomarkers, uses of biomarkers and a method of identifying biomarkers

    Castronovo, Vincenzo; Turtoi, Andrei
    The invention relates to the use of one or more of protein myoferlin, protein latent-transforming growth factor beta binding protein2, protein transforming growth factor beta induced protein ig-h3, protein asporin, protein tenascin, protein periostin, protein galectin, protein fibronectin, protein prolargin, protein protein-glutamine gamma-glutamyl, transferase 2, protein agrin, protein adipocyte enhancer-binding protein 1, protein annexin A6, protein laminin alpha-2 subunit, protein laminin subunit alpha-4, protein mimecan, protein Ras-related protein Rap-2b, protein collagen alpha-1 (XrV) chain, protein, collagen alpha-3 (VI) chain, protein latent-transforming growth factor beta binding protein 1, protein V type proton ATPase catalytic subunit A, protein laminin alpha-4 and protein...

  4. Methods of treating smooth muscle cell disorders

    Verdin, Eric M; Waltregny, David; Castronovo, Vincenzo
    The present invention provides methods of detecting cells showing smooth muscle differentiation. The present invention further provides methods of detecting tumor cells. The present invention further provides compositions and methods for treating smooth muscle cell disorders.

  5. Biomarkers, uses of biomarkers and a method of identifying biomarkers for colorectal carcinoma (CRC) liver metastasis

    Castronovo, Vincenzo; Turtoi, Andrei
    The invention relates to the use of one or more of protein myoferlin, protein latent- transforming growth factor beta binding protein 2, protein transforming growth factor beta induced protein ig-h3, protein adipocyte enhancer-binding protein 1, protein EMILINI, protein periostin, protein CD97, protein prolargin, protein Thy-1 membrane glycoprotein, protein growth hormone inducible transmembrane protein, protein biglycan, protein EPCAM and protein EMILIN2 as a biomarker for colorectal carcinoma (CRC) liver metastasis, or a predisposition thereto. The invention aslo relates to ligands directed to the above-mentioned biomarkers, for use in the therapeutic and/or prophylactic treatment of CRC liver metastasis.

  6. An in-vitro method for screening accessible biological markers in pathologic tissues

    Castronovo, Vincenzo; Waltregny, David; Kischel, Philippe
    An in-vitro method for screening accessible biological markers in pathologic tissues

  7. Establishment of reference values in a healthy population and interpretation of serum PTH concentrations in hemodialyzed patients according to the KDIGO Guidelines using the Lumipulse(R) G whole PTH (3rd generation) assay.

    Cavalier, Etienne; Salse, Margot; Dupuy, Anne-Marie; Bargnoux, Anne-Sophie; WATAR, Florence; Souberbielle, Jean-Claude; DELANAYE, Pierre; Cristol, Jean-Paul
    Peer reviewed

  8. Retour de l'ECCMID

    DESCY, Julie

  9. GUT MICROBIOTA AND FAECAL LEVELS OF SHORT CHAIN FATTY ACIDS DIFFER UPON BLOOD PRESSURE LEVELS IN MAN

    HUART, Justine; Leenders, Justine; Taminiau, Bernard; DESCY, Julie; SAINT-REMY, Annie; Daube, Georges; KRZESINSKI, Jean-Marie; MELIN, Pierrette; De Tullio, Pascal; JOURET, François
    Peer reviewed

  10. Controle de qualité externe - souche de Vibrio cholerae non toxinogène

    MELIN, Pierrette
    Peer reviewed

  11. Contrôle de qualité externe - Souche de Streptococcus agalactiae

    MELIN, Pierrette
    Peer reviewed

  12. Prevention of GBS perinatal Diseases in Europe

    MELIN, Pierrette
    To resume the different strategies recommended in different countries from Europe. To present the recommended methods for group B streptococcal antenatal screening.

  13. Coulisse de la santé du patient : Dédale des prélèvements: 
de l’analyse microbiologique 
au diagnostic

    MELIN, Pierrette; DESCY, Julie
    Parcours d'un échantillon destiné à des analyses microbiologiques: différentes étapes pour aboutir à un diagnostic. Diaporama complété par une video.

  14. Perinatal Group B Streptococcal Disease Towards a European consensus for prevention of GBS perinatal disease: old and new tools

    MELIN, Pierrette

  15. Clinical Impact of New Lab Technologies - Better tests better care: Syndrome-based diagnostics

    MELIN, Pierrette; CEYSSENS, Pieter-Jan

  16. A propos de diphtérie

    DESCY, Julie; PIRET, Sonia
    Cette présentation relate un cas clinique de diphtérie respiratoire à Corynebacterium ulcerans, et aborde la pathogénèse, les manifestations cliniques, l'épidémiologie, le diagnostic microbiologique ainsi que la prise en charge des close contacts en lien avec cette bactérie.

  17. Temocillin susceptibility testing with Vitek2® system and E-test® Are these methods reliable to determine temocillin MIC ?

    DESCY, Julie; VISEE, Clotilde; FRIPPIAT, Frédéric; MEEX, Cécile; LAYIOS, Nathalie; VAN BAMBEKE, Françoise; MELIN, Pierrette
    Background: The use of temocillin (TEM) is increasing in serious infections caused by Enterobacteriaceae, including extended-spectrum β-lactamase (ESBL), as an alternative to carbapenems. Accuracy of in vitro minimal inhibitory concentration (MIC) values is of high importance in an era of antibiotic stewardship based on PK/PD. We performed a method comparison between Vitek2®, E-test® and the standard method, broth microdilution (BMD), in order to evaluate which method is reliable to determine TEM MIC. Materials/methods: One hundred Enterobacteriaceae were collected from respiratory samples isolated from ICU patients. MIC of temocillin was determined in parallel by 3 methods: Vitek2® (Biomérieux), E-test® (Biomérieux) and...

  18. Is Salvage of Recently Infected Breast Implant After Breast Augmentation or Reconstruction Possible? An Experimental Study.

    CASTUS, Pascal; HEYMANS, Olivier; MELIN, Pierrette; RENWART, Ludovic; Henrist, Catherine; HAYTON, E.; MORDON, S.; LECLERE, F.M.
    Peer reviewed

  19. Acide hyaluronique et tendinopathies

    Kaux, Jean-François; SAMSON, Antoine

  20. Sport et cancer

    Kaux, Jean-François; Maquet, Didier; LECLERC, Anne-France

Aviso de cookies: Usamos cookies propias y de terceros para mejorar nuestros servicios, para análisis estadístico y para mostrarle publicidad. Si continua navegando consideramos que acepta su uso en los términos establecidos en la Política de cookies.